Johnson & Johnson (JNJ) Confirms Talks with Actelion on Possible Takeover

November 25, 2016 11:58 AM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Johnson & Johnson (NYSE: JNJ) today confirmed it is engaged in preliminary discussions with Actelion Pharmaceuticals Ltd. (SIX: ATLN) (OTC: ALIOY) regarding a potential transaction.

There can be no assurance any transaction will result from these discussions. Johnson & Johnson does not intend to make any additional comments regarding these discussions unless and until it is appropriate to do so, or a formal agreement has been reached.
StreetInsider first reported on Wednesday that Actelion was a target of a takeover from a major U.S. pharmaceutical company. Bloomberg advanced the story on Thursday/Friday, saying Johnson & Johnson was the bidder.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors

Add Your Comment